Claims for Patent: 12,318,442

✉ Email this page to a colleague

Summary for Patent: 12,318,442

Title:	Preparation of influenza virus vaccine antigens
Abstract:	A number of improvements for preparing vaccine antigens from disintegrated influenza viruses are disclosed. A splitting step can be followed by detergent exchange. Splitting can take place in the presence of a buffer with a higher ionic strength and/or in the presence of phosphate buffer.
Inventor(s):	Christoph Haussmann, Frank Hauschild, Bjorn Jobst
Assignee:	Seqirus UK Ltd
Application Number:	US17/151,840

Details for Patent 12,318,442

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Seqirus Inc.	FLUCELVAX, FLUCELVAX QUADRIVALENT	influenza vaccine	Injection	125408	November 20, 2012	12,318,442	2041-01-19
Seqirus Inc.	FLUCELVAX, FLUCELVAX QUADRIVALENT	influenza vaccine	Injection	125408	March 03, 2021	12,318,442	2041-01-19
Seqirus Inc.	FLUCELVAX, FLUCELVAX QUADRIVALENT	influenza vaccine	Injection	125408	March 26, 2021	12,318,442	2041-01-19
Seqirus Inc.	AUDENZ	influenza a (h5n1) monovalent vaccine, adjuvanted	Injection	125692	January 31, 2020	12,318,442	2041-01-19
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 12,318,442

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2009115917	⤷ Get Started Free
United States of America	2021205438	⤷ Get Started Free
United States of America	2016158341	⤷ Get Started Free
United States of America	2011014230	⤷ Get Started Free
United States of America	10946088	⤷ Get Started Free
New Zealand	587798	⤷ Get Started Free
South Korea	20100135766	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.